Rhodium Complexes of a Chelating Ligand with Imidazol-2-ylidene and Pyridin-2-ylidene Donors: The Effect of <i>C</i>-Metalation of Nicotinamide Groups on Uptake of Hydride Ion by Alex McSkimming (1667020)

“…In <b>3</b> and <b>4</b>, the <i>C</i>-metalated nicotinamide ring is found to exhibit a one-electron reduction process at far lower potential (−2.34 V vs. …”

Rhodium Complexes of a Chelating Ligand with Imidazol-2-ylidene and Pyridin-2-ylidene Donors: The Effect of <i>C</i>-Metalation of Nicotinamide Groups on Uptake of Hydride Ion by Alex McSkimming (1667020)

“…In <b>3</b> and <b>4</b>, the <i>C</i>-metalated nicotinamide ring is found to exhibit a one-electron reduction process at far lower potential (−2.34 V vs. …”

Rhodium Complexes of a Chelating Ligand with Imidazol-2-ylidene and Pyridin-2-ylidene Donors: The Effect of <i>C</i>-Metalation of Nicotinamide Groups on Uptake of Hydride Ion by Alex McSkimming (1667020)

“…In <b>3</b> and <b>4</b>, the <i>C</i>-metalated nicotinamide ring is found to exhibit a one-electron reduction process at far lower potential (−2.34 V vs. …”

Supplementary Material for: The association between dapagliflozin use and the risk of post contrast acute kidney injury in patients with type 2 diabetes and chronic kidney disease:... by Liu T. (2954244)

Supplementary Material for: The association between dapagliflozin use and the risk of post contrast acute kidney injury in patients with type 2 diabetes and chronic kidney disease:... by Liu T. (2954244)

Supplementary Material for: The association between dapagliflozin use and the risk of post contrast acute kidney injury in patients with type 2 diabetes and chronic kidney disease:... by Liu T. (2954244)

Supplementary Material for: The association between dapagliflozin use and the risk of post contrast acute kidney injury in patients with type 2 diabetes and chronic kidney disease:... by Liu T. (2954244)

Identification of the Capzb2 region necessary for binding tubulin and for the effect on tubulin polymerization. by David A. Davis (239142)

“…(F) Tubulin polymerization assay was performed as in <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1000208#pbio-1000208-g004" target="_blank">Figures 4D</a> and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1000208#pbio-1000208-g005" target="_blank">5E</a>, in the presence of 10 µM GST-Capzb2, 10 µM GST-Capzb2Δ106–140, 10 µM GST-Capzb2 C-terminus 141–271, or 10 µM GST-Capza2. …”

EAEC combines with <i>Giardia</i> to enhance microbial host co-metabolic perturbations and co-infection exhausts regulatory host energy expenditure adaptations during malnutrition. by Luther A. Bartelt (401636)

“…(C,D) OPLS-DA correlation coefficient plots indicating the variation between (C) <i>Giardia</i> infected (Day 13) and uninfected PBS controls (Day 13) (Q²Y = 0.40; P = 0.02) or (D) co-infection (Day 13) versus EAEC mono-infection (Day 13) (Q²Y = 0.82; p = 0.001) (n = 4-5/group). Correlation coefficients plots were generated with the use of a back-scaling transformation to display the contribution of each metabolite to the sample classification. …”

Data_Sheet_1_Effects of Dexmedetomidine on Emergence Agitation and Recovery Quality Among Children Undergoing Surgery Under General Anesthesia: A Meta-Analysis of Randomized Contro... by Xiaoli Yang (314226)

“…Furthermore, children in the dexmedetomidine group experienced a longer emergence time [mean difference (MD) 2.18; 95% CI 0.81–3.56; p = 0.002] and extubation time (MD 0.77; 95% CI 0.22–1.31; p = 0.006) compared with those in the saline group. …”

Sulfates of the Refractory Metals: Crystal Structure and Thermal Behavior of Nb₂O₂(SO₄)₃, MoO₂(SO₄), WO(SO<sub>4</... by Ulf Betke (2233432)

“…WO(SO₄)₂ (monoclinic, <i>P</i>2₁/<i>n</i>, <i>a</i> = 7.453(1) Å, <i>b</i> = 11.8232(8) Å, <i>c</i> = 7.881(1) Å, β = 107.92(2)°, <i>V</i> = 660.7(1) ų, <i>Z</i> = 4) and both modifications of Re₂O₅(SO₄)₂ (I: orthorhombic, <i>Pba</i>2, <i>a</i> = 9.649(1) Å, <i>b</i> = 8.4260(8) Å, <i>c</i> = 5.9075(7) Å, <i>V</i> = 480.27(9) ų, <i>Z</i> = 2; II: orthorhombic, <i>Pbcm</i>, <i>a</i> = 7.1544(3) Å, <i>b</i> = 7.1619(3) Å, <i>c</i> = 16.8551(7) Å, <i>V</i> = 863.64(6) ų, <i>Z</i> = 4) are the first structurally characterized examples of tungsten and rhenium oxide sulfates. …”

Sulfates of the Refractory Metals: Crystal Structure and Thermal Behavior of Nb₂O₂(SO₄)₃, MoO₂(SO₄), WO(SO<sub>4</... by Ulf Betke (2233432)

“…WO(SO₄)₂ (monoclinic, <i>P</i>2₁/<i>n</i>, <i>a</i> = 7.453(1) Å, <i>b</i> = 11.8232(8) Å, <i>c</i> = 7.881(1) Å, β = 107.92(2)°, <i>V</i> = 660.7(1) ų, <i>Z</i> = 4) and both modifications of Re₂O₅(SO₄)₂ (I: orthorhombic, <i>Pba</i>2, <i>a</i> = 9.649(1) Å, <i>b</i> = 8.4260(8) Å, <i>c</i> = 5.9075(7) Å, <i>V</i> = 480.27(9) ų, <i>Z</i> = 2; II: orthorhombic, <i>Pbcm</i>, <i>a</i> = 7.1544(3) Å, <i>b</i> = 7.1619(3) Å, <i>c</i> = 16.8551(7) Å, <i>V</i> = 863.64(6) ų, <i>Z</i> = 4) are the first structurally characterized examples of tungsten and rhenium oxide sulfates. …”

Sulfates of the Refractory Metals: Crystal Structure and Thermal Behavior of Nb₂O₂(SO₄)₃, MoO₂(SO₄), WO(SO<sub>4</... by Ulf Betke (2233432)

“…WO(SO₄)₂ (monoclinic, <i>P</i>2₁/<i>n</i>, <i>a</i> = 7.453(1) Å, <i>b</i> = 11.8232(8) Å, <i>c</i> = 7.881(1) Å, β = 107.92(2)°, <i>V</i> = 660.7(1) ų, <i>Z</i> = 4) and both modifications of Re₂O₅(SO₄)₂ (I: orthorhombic, <i>Pba</i>2, <i>a</i> = 9.649(1) Å, <i>b</i> = 8.4260(8) Å, <i>c</i> = 5.9075(7) Å, <i>V</i> = 480.27(9) ų, <i>Z</i> = 2; II: orthorhombic, <i>Pbcm</i>, <i>a</i> = 7.1544(3) Å, <i>b</i> = 7.1619(3) Å, <i>c</i> = 16.8551(7) Å, <i>V</i> = 863.64(6) ų, <i>Z</i> = 4) are the first structurally characterized examples of tungsten and rhenium oxide sulfates. …”

Sulfates of the Refractory Metals: Crystal Structure and Thermal Behavior of Nb₂O₂(SO₄)₃, MoO₂(SO₄), WO(SO<sub>4</... by Ulf Betke (2233432)

“…WO(SO₄)₂ (monoclinic, <i>P</i>2₁/<i>n</i>, <i>a</i> = 7.453(1) Å, <i>b</i> = 11.8232(8) Å, <i>c</i> = 7.881(1) Å, β = 107.92(2)°, <i>V</i> = 660.7(1) ų, <i>Z</i> = 4) and both modifications of Re₂O₅(SO₄)₂ (I: orthorhombic, <i>Pba</i>2, <i>a</i> = 9.649(1) Å, <i>b</i> = 8.4260(8) Å, <i>c</i> = 5.9075(7) Å, <i>V</i> = 480.27(9) ų, <i>Z</i> = 2; II: orthorhombic, <i>Pbcm</i>, <i>a</i> = 7.1544(3) Å, <i>b</i> = 7.1619(3) Å, <i>c</i> = 16.8551(7) Å, <i>V</i> = 863.64(6) ų, <i>Z</i> = 4) are the first structurally characterized examples of tungsten and rhenium oxide sulfates. …”

Sulfates of the Refractory Metals: Crystal Structure and Thermal Behavior of Nb₂O₂(SO₄)₃, MoO₂(SO₄), WO(SO<sub>4</... by Ulf Betke (2233432)

“…WO(SO₄)₂ (monoclinic, <i>P</i>2₁/<i>n</i>, <i>a</i> = 7.453(1) Å, <i>b</i> = 11.8232(8) Å, <i>c</i> = 7.881(1) Å, β = 107.92(2)°, <i>V</i> = 660.7(1) ų, <i>Z</i> = 4) and both modifications of Re₂O₅(SO₄)₂ (I: orthorhombic, <i>Pba</i>2, <i>a</i> = 9.649(1) Å, <i>b</i> = 8.4260(8) Å, <i>c</i> = 5.9075(7) Å, <i>V</i> = 480.27(9) ų, <i>Z</i> = 2; II: orthorhombic, <i>Pbcm</i>, <i>a</i> = 7.1544(3) Å, <i>b</i> = 7.1619(3) Å, <i>c</i> = 16.8551(7) Å, <i>V</i> = 863.64(6) ų, <i>Z</i> = 4) are the first structurally characterized examples of tungsten and rhenium oxide sulfates. …”

Treatment with the ILK Inhibitor QLT-0267 Results in Aberrant Cytokinesis and Mitotic Spindle Disorganization. by William K. A. Sikkema (574881)

“…<p>(A) A dramatic decrease in F-actin staining was observed in Y79 cells after a 5-day incubation to 10 µM QLT-0267 (n = 4). …”

Upstream dam impacts on gilded catfish Brachyplatystoma rousseauxii (Siluriformes: Pimelodidae) in the Bolivian Amazon by Paul A. Van Damme (8074823)

C57BL/6 mice chronically infected with the <i>LiΔHSP70-II</i> showed a Th1 like response against <i>Leishmania</i>. by José Carlos Solana (4053745)

“…No statistical differences were found in the parasite burdens in the RP from week 4 to week 12 whereas a significant decrease was shown in the RFP (unpaired Student t-test). …”

Effect of miRNAs on wound healing. by Vincent A. Funari (255249)

Performance is temporarily reduced after anoxic coma induced by water immersion. by Tomas G. A. Money (522109)

“…(<b>B</b>). The reduction in mean spike count is most prominent at 1 hour of recovery, and gradually returns to control levels over a period of 5 hours. …”